- Home
- BIOA vs ITIC Comparison
BIOA vs ITIC Comparison
Compare BIOA & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BIOA | ITIC |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.0M | 545.6M |
| IPO Year | 2024 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BIOA | ITIC |
|---|---|---|
| Price | $7.11 | $288.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $51.50 | N/A |
| AVG Volume (30 Days) | ★ 621.6K | 42.6K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.43% |
| EPS Growth | ★ 66.21 | 13.02 |
| EPS | N/A | ★ 10.93 |
| Revenue | $8,995,000.00 | ★ $272,755,000.00 |
| Revenue This Year | $720.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $26.48 |
| Revenue Growth | N/A | ★ 5.60 |
| 52 Week Low | $5.05 | $209.75 |
| 52 Week High | $25.96 | $309.55 |
Technical Indicators
Market Signals| Indicator | BIOA | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 28.10 | 45.16 |
| Support Level | N/A | $284.50 |
| Resistance Level | $8.53 | $294.88 |
| Average True Range (ATR) | 0.48 | 6.95 |
| MACD | 0.10 | -1.44 |
| Stochastic Oscillator | 7.11 | 27.93 |
Price Performance
Historical ComparisonAbout BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The Company has two reportable segments. The Company's primary business activity, and one of its reportable operating segments, is the issuance of residential and commercial title insurance through ITIC and NITIC. The company's second reportable operating segment is providing tax-deferred real property exchange services through its subsidiaries, Investors Title Exchange Corporation (ITEC) and Investors Title Accommodation Corporation (ITAC).